BioInvest ApS: Financial statements 2020
CVR: 41998288
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
BioInvest ApS (CVR 41998288) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -20,000 and a net result of DKK 81,549,502. Equity in the 2020 report amounted to DKK 103,300,070. The solvency ratio was 99.3%.
- Gross Profit
- DKK -20,000
- Profit/Loss
- DKK 81,549,502
- Equity
- DKK 103,300,070
- Total Assets
- DKK 103,980,072
- Employees
- 0
Official annual report
How creditworthy is BioInvest ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of December 30, 2020, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of BioInvest ApS.
As of December 30, 2020, Jeppe Øvli Øvlesen is registered as director of BioInvest ApS.
As of December 30, 2020, Thomas Engelbrecht Nordkild Jonassen is registered as director of BioInvest ApS.
BioInvest ApS was founded on December 30, 2020.
About BioInvest ApS
BioInvest ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. According to the 2022 annual report, the company had an average of 0 employees. In 2022, the company reported a gross profit of DKK -12,500 and a net result of DKK -183,766,349 compared with DKK 284,250,983 the year before. Equity in the 2022 report amounted to DKK 203,784,704.